1. Home
  2. NAGE vs DGICA Comparison

NAGE vs DGICA Comparison

Compare NAGE & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAGE
  • DGICA
  • Stock Information
  • Founded
  • NAGE 1999
  • DGICA 1986
  • Country
  • NAGE United States
  • DGICA United States
  • Employees
  • NAGE N/A
  • DGICA N/A
  • Industry
  • NAGE Medicinal Chemicals and Botanical Products
  • DGICA Property-Casualty Insurers
  • Sector
  • NAGE Health Care
  • DGICA Finance
  • Exchange
  • NAGE Nasdaq
  • DGICA Nasdaq
  • Market Cap
  • NAGE 766.4M
  • DGICA 711.2M
  • IPO Year
  • NAGE N/A
  • DGICA N/A
  • Fundamental
  • Price
  • NAGE $10.10
  • DGICA $19.25
  • Analyst Decision
  • NAGE Strong Buy
  • DGICA Hold
  • Analyst Count
  • NAGE 3
  • DGICA 1
  • Target Price
  • NAGE $17.00
  • DGICA $18.00
  • AVG Volume (30 Days)
  • NAGE 791.2K
  • DGICA 140.5K
  • Earning Date
  • NAGE 10-30-2025
  • DGICA 10-23-2025
  • Dividend Yield
  • NAGE N/A
  • DGICA 3.81%
  • EPS Growth
  • NAGE N/A
  • DGICA 965.80
  • EPS
  • NAGE 0.22
  • DGICA 2.34
  • Revenue
  • NAGE $116,303,000.00
  • DGICA $993,644,532.00
  • Revenue This Year
  • NAGE $29.05
  • DGICA $2.26
  • Revenue Next Year
  • NAGE $21.09
  • DGICA $2.96
  • P/E Ratio
  • NAGE $44.84
  • DGICA $8.18
  • Revenue Growth
  • NAGE 35.90
  • DGICA 3.36
  • 52 Week Low
  • NAGE $3.18
  • DGICA $14.06
  • 52 Week High
  • NAGE $14.69
  • DGICA $21.12
  • Technical
  • Relative Strength Index (RSI)
  • NAGE 56.52
  • DGICA 59.27
  • Support Level
  • NAGE $9.42
  • DGICA $18.90
  • Resistance Level
  • NAGE $9.92
  • DGICA $19.49
  • Average True Range (ATR)
  • NAGE 0.40
  • DGICA 0.50
  • MACD
  • NAGE 0.06
  • DGICA 0.04
  • Stochastic Oscillator
  • NAGE 98.08
  • DGICA 71.71

About NAGE Niagen Bioscience Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

About DGICA Donegal Group Inc.

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

Share on Social Networks: